Ibima
KNOW US
Get to know us
Annual Scientific Report
Transparency
Plan Estratégico
Our Location
News
STRUCTURE
Organizational Structure
Organisational Chart
Delegated Commission
External Scientific Committee
Management team
Management Areas
Investigation
Research Areas / Groups
Clinical Research
Announcements
Plan
Affiliation Policy
Innovation
Protección del Conocimiento
Research Support
Nanoimaging
Methodological and Statistical Advising
Animal Housing Facility
Biobank
Bioinformatics
Cell Cultures
Genomics
Histology
Laboratorio de Biología Celular
Proteomics
Cellular Manufacturing and GMP Rooms
Chemistry
Talent
Working with us
HR Strategy
Public Offers of Employment
Continuous training
Researcher Career
International Talent
Society
Buscar:
Botón de búsqueda
Seleccionar página
Resultados para "Pedro Serrano Castro"
Buscar:
Botón de búsqueda
Entradas
PEDRO JESÚS SERRANO CASTRO
CKD: The burden of disease invisible to research funders
Prevalence of Neural Autoantibodies in Paired Serum and Cerebrospinal Fluid in Adult Patients with Drug-Resistant Temporal Lobe Epilepsy of Unknown Etiology
Prevalence of Neural Autoantibodies in Paired Serum and Cerebrospinal Fluid in Adult Patients with Drug-Resistant Temporal Lobe Epilepsy of Unknown Etiology.
GABAergic deficits in absence of LPA1 receptor, associated anxiety-like and coping behaviors, and amelioration by interneuron precursor transplants into the dorsal hippocampus.
Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study
PECOVID-0099-2020 Estudio Neuro-Covid: secuelas neurológicas y estudio de biomarcadores en pacientes incidentes con infección por Coronavirus SARS-CoV-2.
COV20/00157 Afectación neurológica en la enfermedad Covid-19 clinicamente relevante. ¿Existe la enfermedad Neuro-Covid-19?
RIC-0111-2019. RED ANDALUZA DE INVESTIGACIÓN CLÍNICA y TRASLACIONAL EN NEUROLOGÍA (NEURO-RECA)
Páginas
IBIMA Rare
Area 3
Management team
Proyectos
C-01